Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 28Unknown 11Recruiting 7Withdrawn 5Terminated 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Neoplasms 33Breast Neoplasms 26Colorectal Neoplasms 21Prostatic Neoplasms 18Uterine Cervical Neoplasms 13Anxiety Disorders 13Lung Neoplasms 7Urinary Bladder Neoplasms 6Lymphoma, Follicular 6Colonic Neoplasms 6Brain Neoplasms 6Pain 5Epilepsy 5Depression 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Dysplasia 4Ovarian Neoplasms 4Inflammation 4Head and Neck Neoplasms 4Dementia 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Smoking 3Sarcoma 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplastic Syndromes, Hereditary 3Motor Activity 3Lymphedema 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Enrolling by invitation × Neuroblastoma × Clear all
NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Universitaire Ziekenhuizen KU Leuven

Phase NA Enrolling by invitation
1,600 enrolled
CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡